Search for: "United States v. Purify" Results 61 - 69 of 69
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jul 2010, 11:07 am by Jason Rantanen
  Although as a practical matter this distinction may be of little value, as pharmaceutical companies often have production facilities located outside the United States, it is something to consider when seeking or opposing litigation under § 156. [read post]
31 Mar 2010, 6:28 am by The Docket Navigator
United States Patent and Trademark Office et al., 1-09-cv-04515 (NYSD March 29, 2010, Opinion) (Sweet, J.) [read post]
24 Jun 2009, 10:17 am
There was much argument around the claim because the claim just stated the name of the enantiomer, just as some claims merely state the name of the virus or gene or protein. [read post]
26 Sep 2007, 1:04 pm
Purepac Pharma, Faulding, Watson Pharma, Danbury Pharma, Teva, Zenith Labs, Ivax, Apotex, Torpharm and Eon Labs) United States Court of Appeals for the Federal Circuit (06-1572). [read post]